We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
MSGM | Motorsport Games Inc | 1.42 | 0.32 | 29.09% | 2,345,657 |
ELYM | Eliem Therapeutics Inc | 8.38 | 1.82 | 27.74% | 236,697 |
VSME | VS Media Holdings Ltd | 1.57 | 0.34 | 27.64% | 1,851,307 |
XHG | XChange TED Inc | 1.45 | 0.25 | 20.83% | 968,242 |
FRZA | Forza X1 Inc | 0.33 | 0.0499 | 17.82% | 20 |
MCVT | Mill City Ventures III Ltd | 2.73 | 0.38 | 16.17% | 388 |
BSLK | Bolt Projects Holdings Inc | 0.99 | 0.13 | 15.12% | 4 |
VERO | Venus Concept Inc | 0.70 | 0.0848 | 13.78% | 80 |
CELZ | Creative Medical Technology Holdings Inc | 3.50 | 0.4095 | 13.25% | 8 |
TNON | Tenon Medical Inc | 4.55 | 0.53 | 13.18% | 531,864 |
KLTO | Klotho Neurosciences Inc | 0.9221 | 0.0932 | 11.24% | 82 |
Vertex Energy, Inc. (NASDAQ: VTNR) ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, today announced it entered into a Restructuring Support Agreement (the “RSA”) with overwhelming support of 100% of the Company’s term loan lenders (the “Consenting Term Loan Lenders”). To facilitate the transactions contemplated under the RSA, including exploration of a sale transaction, the Company commenced Chapter 11 cases in the United States Bankruptcy Court for the Southern District of Texas.
The Company's intellectual property now covers the combination, formulation, and method of use of PrimeCPatent protection extends through 2042, adding four additional years to PrimeC's IP umbrellaCAMBRIDGE, Mass., Sept. 24, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced the issuance of a pivotal patent by the United States Patent and Trademark Office (USPTO). The newly granted patent, entitled "Compositions comprising Ciprofloxacin and Celecoxib" (US Patent No. US 12,097,185), relates to the novel formulation of PrimeC, NeuroSense's leading drug candidate for the treatment of Amyotrophic Lateral ...
SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- XChange TEC.INC (NASDAQ: XHG) (the "Company"), today announced that on September 24, 2024, the Company entered into a Securities Purchase Agreement with VG Master Fund SPC ("VG") pursuant to which the Company may from time to time sell VG up to $25.0 million of American Depositary Shares ("ADSs") with each ADSs representing 600,000 of the Company's Class A Ordinary Shares. The timing of any such sales, are solely at the Company's option, and the Company is under no obligation to sell any securities to VG under the Purchase Agreement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvve-updates-shareholders-on-compliance-measures-302257834.html SOURCE Nuvve Holding Corp.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 63,868.61 | -400.04 | -0.62% | 1.25T | 3,837,856,900 |
ETH | Ethereum | 2,628.86 | -24.49 | -0.92% | 315.42B | 2,060,744,857 |
USDT | Tether USD | 0.99994 | -0.00002 | 0.00% | 97.84B | 194,699,556 |
BNB | Binance Coin | 597.71 | -8.15 | -1.34% | 94.29B | 216,040,360 |
SOL | Solana | 150.60 | -2.15 | -1.41% | 66.26B | 1,124,215,531 |
XRP | Ripple | 0.5898 | -0.0015 | -0.25% | 32.12B | 224,041,964 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 900,836,452 |
STETH | stETH | 2,627.76 | -25.59 | -0.96% | 25.65B | 4,421,399 |
TONCOIN | Wrapped TON Coin | 5.69 | 0.085457 | 1.52% | 19.57B | 79,115,481 |
DOGE | Dogecoin | 0.10922 | -0.00051 | -0.46% | 15.64B | 179,216,419 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions